Time is Brain’s Post

Revolutionizing Healthcare with Emerging HealthTech Startups! Discover the future of patient care with innovative startups like Notable Labs, Tempus, and Butterfly Network. These trailblazers are transforming cancer treatment, precision medicine, and medical imaging. Stay ahead of the curve and explore how these companies are set to disrupt the healthcare industry in 2024. 🌐🩺 #HealthTech #Innovation #FutureOfHealthcare

👉 𝐐𝐮𝐢𝐜𝐤 𝐁𝐲𝐭𝐞𝐬: French medtech startup Raidium has secured $13 million in seed funding to advance its AI-powered precision diagnostics platform. The funding round was led by Newfund and Kurma Partners, with participation from Founders Future, Galion.exe, and the European EIC IMPACT TRUST - EIC IMPACT FUND (Eastern Investment Centers). Raidium has developed the world's first radiological AI-native foundation model, offering a holistic and multimodal approach to precision radiology. This technology enables detailed 3D segmentation, advanced measurements, and automated analysis of complex biomarkers with unprecedented speed—2,500 times faster than manual methods. The platform is designed to address the complex needs of both clinical trials and clinical practice, providing faster, more accurate, and scalable insights for cases like metastatic cancer tracking and whole-body diagnostics. By automating routine tasks, Raidium aims to enhance productivity and diagnostic accuracy, making legal services more accessible and affordable. In less than two years, Raidium has established partnerships with academic centers in France and secured its first contracts with pharmaceutical clients, underscoring its rapid growth and the increasing demand for AI-driven solutions in healthcare. #AI #Radiology #PrecisionDiagnostics #HealthcareInnovation #MedTech #StartupFunding #Raidium #MedicalImaging #ClinicalTrials #HealthcareTechnology #UKIndia | Paul Herent, M.D., Msc | Pierre Manceron | Sebastian Schwarz

Quibim is setting a bold new standard in the realm of medical imaging, armed with an extraordinary $50 million in #Series-B #funding. This Valencia-based innovator is at the vanguard of AI-driven solutions that are reshaping diagnostic workflows, from oncology to neurology, enabling faster, more accurate, and earlier detection of critical health conditions. Quibim’s AI-powered tools extract vital biomarkers from medical images, providing doctors with sharper, more reliable insights to drive better patient outcomes. By integrating seamlessly into existing radiology systems, Quibim's technology addresses the real-world challenge of subjective image interpretation, ensuring that even the smallest anomalies do not go unnoticed. With the global medical imaging market expected to reach $50 billion by 2030, Quibim is positioned to seize a significant share of this growth. Their solutions are poised to revolutionize industries where early intervention is paramount—particularly in the battle against chronic conditions like cancer and Alzheimer’s, where a timely diagnosis can save lives. Backed by the expertise of top #investors, Quibim is accelerating its research and development, expanding its AI model library, and forging partnerships with hospitals and research institutions worldwide. The future of #healthcare diagnostics is here, and Quibim is leading the way with precision, #vision, and unmatched potential. #fundings #venture #strategy #innovation #entrepreneur

The speed at which AI is being adopted in diagnostics in the U.S. is remarkable, and keeping pace with this rapid progress is becoming an ever-growing challenge for European manufacturers, startups, and healthcare providers alike. https://lnkd.in/gkA7mG_b

HealthTech Quibim's vision for human digital twins gets €47.9M boost Quibim, a Valencia-based HealthTech company focused on innovative imaging biomarkers, has recently secured €47.9 million in Series A funding to enhance its presence in the United States. This funding was led by prominent investors including Asabys and Buenavista Equity Partners, further supported by existing investors such as Amadeus Capital and Partech. This investment is crucial for Quibim as they aim to revolutionize diagnostics and patient outcomes through advanced imaging technologies. Founded in 2012 by Dr. Ángel Alberich-Bayarri and Luis Martí Bonmatí, the company strives to provide a comprehensive, non-invasive understanding of human tissue using AI models. Their specific focus on creating “digital twins” allows for meticulous health monitoring and treatment adaptability. In an era where the demand for precision medicine is exponentially rising, Quibim’s solutions play a significant role. Their flagship products, such as QP-Prostate and QP-Liver, utilize AI to improve early detection and diagnosis of diseases, particularly in oncology and neurology. Did you know that Quibim is already operational in over 170 installations globally, including prestigious institutions like Mass General Brigham and Stanford? The growing need for precise healthcare solutions indicates that these innovations will soon be paramount in clinical settings. What are your thoughts on the potential of digital twins in healthcare? How do you envision technology shaping the future of diagnostics? Share your insights! #HealthTech #DigitalTwins #ImagingBiomarkers #PrecisionMedicine #Investment #Quibim #AIinHealthcare Source: "https://lnkd.in/dsFvJt_e"

Viseur AI and Biyovisio Strategic Partnership Announcement 🔔🤝 We are proud to announce our exciting collaboration with Biyovisio, which uses to deliver highly accurate cancer screening from MRI and CT scans. Together, we aim to create reliable, solution-orientated and cutting-edge approaches to overcome healthcare challenges.                                                                                                                           Combining Biyovisio's expertise in medical imaging analysis and Viseur AI's strength in AI, this collaboration will take our AI-powered healthcare solutions, especially in radiology, to a new level in the global market.                                                                                                                            This partnership will also help us accelerate digital transformation in healthcare by offering user-friendly information management systems designed to streamline the workflows of healthcare professionals. #ViseurAI #Biyovisio #Partnership #Biotechnology #MedicalAI #Startups #Biotech #HealthcareTechnology #Enterprise #Innovation #Technology #ArtificialIntelligence #Associate #Radiology

Health tech startup Quibim is closing in on its goal to take precision medicine to the next level via advanced imaging technology after a US$50m fundraise: https://lnkd.in/eQ6BZfUc #imaging #finance #healthtech

The Future of HealthTech is Here! Emerging startups are driving the next wave of healthcare innovation. From AI-powered diagnostics by Zebra Medical Vision to early cancer detection by GRAIL, these companies are revolutionizing patient care. Stay informed about these game-changers and their potential to reshape the health tech landscape. 🚀🩺 #HealthTechStartups #MedicalInnovation #FutureOfMedicine

🚨 Breaking: InterVene, Inc. Secures $13M Series A Funding to Revolutionize Deep Vein Treatment 💥 InterVene, a Redwood City-based medtech leader, is pushing boundaries in chronic venous disease treatment. Here’s how they’re advancing vascular health with the recent Series A round: What’s Driving This Innovation: • Lead by Treo Ventures & RiverVest Venture Partners: Funding secured for final Recana catheter system development, clinical trials, and U.S. regulatory submission. 💰 • New Leadership Addition: Treo Ventures' Brad Vale joins InterVene’s Board, bringing deep expertise in medtech scaling. Why Recana is a Game-Changer: • Precision in Deep Vein Treatment: Recana is designed for recanalization in chronic deep vein obstructions, especially where conventional solutions fall short. • Seamless for Specialists: Uses Fluoroscopy/IVUS-guided techniques, aligning with methods already familiar to vascular specialists. ⚙️ Built on a Strong Foundation: Developed with support from the Stanford Biodesign Fellowship and residency at the Fogarty Institute, InterVene’s team of interventional experts is set to lead in deep venous care. The path to initial commercialization and post-market research is set, positioning InterVene as a significant player in venous disease innovation. 📢 Stay tuned to Future Techly for the latest updates on this groundbreaking initiative and the latest in tech and business! 💥 Source: FinSMEs ♻️ Repost if you think this insight is worth sharing!

Paris-based Raidium secures €16M in seed funding to revolutionize medical imaging. Co-led by Newfund and Kurma Partners, with participation from Galion.exe, Founders Future, Debiopharm, Techmind, and European Innovation Council and SMEs Executive Agency (EISMEA), this funding will support Raidium’s mission to enhance radiology through cutting-edge 3D Large Vision Language models for CT scans and MRIs. Founded by Paul Herent, M.D., Msc and Pierre Manceron, Raidium is pioneering precision medicine with innovative biomarkers, a world-class team, and a user interface designed for radiologists. Stay ahead in the startup world! 🌟 Get a weekly digest of key happenings and insights delivered to your inbox every Monday morning. Don't miss out—subscribe now: https://lnkd.in/eJXZrmEj] 🚀 #Funding #HealthTech #MedicalImaging #Innovation